Treatment of Chronic Fatigue Syndrome: Findings, Principles and Strategies
Patrick Luyten, Boudewijn Van Houdenhove, Chi-Un Pae, Stefan Kempke, Peter Van Wambeke
Psychiatry Investig. 2008;5(4):209-212.   Published online 2008 Dec 31     DOI:
Time-dependent complexity characterisation of activity patterns in patients with Chronic Fatigue Syndrome
Paloma Rabaey, Peter Decat, Stefan Heytens, Dirk Vogelaers, An Mariman, Thomas Demeester
BioPsychoSocial Medicine.2024;[Epub]     CrossRef
Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome
Jesus Castro‐Marrero, Naia Sáez‐Francàs, Dafna Santillo, Jose Alegre
British Journal of Pharmacology.2017; 174(5): 345.     CrossRef
Moxibustion upregulates hippocampal progranulin expression
Tao Yi, Li Qi, Ji Li, Jing-jing Le, Lei Shao, Xin Du, Jing-cheng Dong
Neural Regeneration Research.2016; 11(4): 610.     CrossRef
Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study
Joel L. Young
Psychiatry Research.2013; 207(1-2): 127.     CrossRef
Chronic fatigue syndrome – A neuroimmunological model
S.V. Arnett, L.M. Alleva, R. Korossy-Horwood, I.A. Clark
Medical Hypotheses.2011; 77(1): 77.     CrossRef
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants
Chi-Un Pae, David M Marks, Ashwin A Patkar, Prakash S Masand, Patrick Luyten, Alessandro Serretti
Expert Opinion on Pharmacotherapy.2009; 10(10): 1561.     CrossRef
The Effects of Galantamine Hydrobromide Treatment on Dehydroepiandrosterone Sulfate and Cortisol Levels in Patients with Chronic Fatigue Syndrome
Tayfun Turan, Hasan Basri Izgi, Saliha Ozsoy, Fatih Tanrıverdi, Mustafa Basturk, Akif Asdemir, Aslı Beşirli, Ertugrul Esel, Seher Sofuoglu
Psychiatry Investigation.2009; 6(3): 204.     CrossRef